Supplementary Figure 5 from GSK-3α Promotes Oncogenic KRAS Function in Pancreatic Cancer via TAK1–TAB Stabilization and Regulation of Noncanonical NF-κB

Abstract

PDF file - 63K, GSK-3 inhibition inhibits TAK1 mediated signaling. Panc-1 cells were treated with GSK-3 inhibitor, AR-A014418 (30M) for 24 hours and whole cell lysates immunoblotted for indicated antibodies.</p